P714-0033 Screening compound: N-(2-fluoro-5-methylphenyl)-2-[6-(3-methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide

P714-0033 Screening compound: N-(2-fluoro-5-methylphenyl)-2-[6-(3-methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide
P714-0033 Screening compound: N-(2-fluoro-5-methylphenyl)-2-[6-(3-methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P714-0033
N-(2-fluoro-5-methylphenyl)-2-[6-(3-methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P714-0033

Molecular Formula

C18H15FN6O2 (C18 H15 FN6 O2)

Compound Name

N-(2-fluoro-5-methylphenyl)-2-[6-(3-methyl-1,2,4-oxadiazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]acetamide

IUPAC name

N-(2-fluoro-5-methylphenyl)-2-[6-(3-methyl-124-oxadiazol-5-yl)-[124]triazolo[43-a]pyridin-3-yl]acetamide

SMILES

Cc1noc(-c(cc2)cn3c2nnc3CC(Nc(cc(C)cc2)c2F)=O)n1

InChI

InChI=1S/C18H15FN6O2/c1-10-3-5-13(19)14(7-10)21-17(26)8-16-23-22-15-6-4-12(9-25(15)16)18-20-11(2)24-27-18/h3-7,9H,8H2,1-2H3,(H,21,26)

InChI Key

FSPOWBBCDUNRJT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613804

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

366.35

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.693

Distribution Coefficient, logD

1.692

Water Solubility, LogSw

-2.21

Polar Surface Area

76.188

Acid Dissociation Constant (pKa)

11.02

Base Dissociation Constant (pKb)

1.63

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

P714-0033 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P714-0033 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P714-0033?
Check Price and Availability of P714-0033, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P714-0033 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P714-0033
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P714-0033
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P714-0033 available by request